This inventor holds 2 USPTO granted patents. Top assignee: The United States of America as Represented by the United States. Active years: 1988.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Del Mar, CA (US) (1988)
- San Diego, CA (US) (1988)
Company Filing History:
Years Active: 1988
Title: The Innovative Contributions of Stella S. Fong
Introduction
Stella S. Fong is a prominent inventor based in Del Mar, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 2 patents, her work has the potential to impact various medical applications.
Latest Patents
Stella's latest patents include groundbreaking advancements in cell lines for the production of monoclonal antibodies to human glycophorin A. The cloned mouse hybridoma cell lines she established continuously produce antibodies that differentiate between the M and N forms of human glycophorin A. These antibodies have potential applications as human blood group reagents, markers for terminally differentiated erythroid cells, and immunofluorescent labels of somatically variant human erythrocytes. Additionally, her work on monoclonal antibodies to human glycophorin A has led to the creation of cell lines that are highly specific and exhibit high affinity for glycophorin A.sup.N.
Career Highlights
Stella has had a remarkable career, contributing to significant advancements in her field. Her innovative research has positioned her as a leader in the development of monoclonal antibodies, which are crucial for various diagnostic and therapeutic applications.
Collaborations
Stella has collaborated with notable colleagues, including Martin Vanderlaan and William L. Bigbee. These partnerships have further enhanced her research and contributed to the success of her projects.
Conclusion
Stella S. Fong's contributions to biotechnology through her patents and research are invaluable. Her work continues to pave the way for advancements in medical science and diagnostics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
